Regional Analysis
North America is expected to be the largest market for controlled substance market during the forecast period, which is expected to account for over 35.9% of the market share in 2023. The market growth in North America is due to the high burden of chronic diseases and increasing prevalence of prescription drug abuse in the region.
The Europe market is expected to be the second-largest market for controlled substance market, which is expected to account for over 28.5% of the market share in 2023. The market growth in Europe is due to the rising geriatric population and increasing use of controlled drugs.
The Asia Pacific market is expected to be the fastest-growing market for controlled substance market, with a CAGR of over 5.5% during the forecast period. The market growth in Asia Pacific is due to the improving healthcare infrastructure and growing awareness about controlled substances.
Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|
U.S.: 
U.K. : 
India : 
